GRAIL INC (GRAL) Stock News
NASDAQ:GRAL - Nasdaq - US3847471014 - Common Stock - Currency: USD
GRAL Latest News, Press Relases and Analysis
3 Medical Technology Stocks Outperforming in 2025
Three med-tech stocks, TransMedics, Insulet, and GRAIL, are outperforming the market and their sector while forming bullish technical patterns.
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
/PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has...
Stock Market News for May 23, 2025
U.S. stocks markets closed mixed after a choppy session.
GRAIL to Present at Jefferies Global Healthcare Conference 2025
/PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company...
Shake Shack, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
GRAIL Reports First Quarter 2025 Financial Results
/PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and...
GRAIL to Announce First Quarter 2025 Financial Results
/PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will...
Endava Sees No Relief Up Ahead
Endava beat EPS estimates, but the company lowered full-year guidance on continued macro headwinds. Endava saw its number of big-spending clients fall, and it is more reliant than ever on its top customers. Until large corporations have more clarity about the economy, Endava is unlikely to see a significant uptick in new business.
GRAIL to Announce Fourth Quarter 2024 Financial Results
/PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will...
GRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test
/PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced a new...
Why GRAIL, Inc. (GRAL) is Surging in 2025
We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where GRAIL, Inc. (NASDAQ:GRAL) stands against other healthcare stocks that are surging in 2025. After lagging behind the broader market in 2024, many healthcare stocks are making a comeback […]
GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting
/PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, will present new data...
Illumina, Inc. (ILMN): Among Recent Activist Investor Campaigns
We recently published a list of 15 Recent Activist Investor Campaigns. In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against other recent activist investor campaigns. Economic uncertainty and market volatility are some of the factors fueling activist investor campaigns in 2025. In the first quarter alone, there […]
Math to money: A student financial aid expert’s journey
Mark Kantrowitz, a nationally recognized student financing expert, shares what he’s learned in 30 years observing the industry.
GRAIL, Inc. (GRAL): A Bull Case Theory
We came across a bullish thesis on GRAIL, Inc. (GRAL) on Value Investing Subreddit Page by mike-some. In this article, we will summarize the bulls’ thesis on GRAL. GRAIL, Inc. (GRAL)’s share was trading at $25.93 as of April 15th. Grail, the undisputed leader in multi-cancer early detection (MCED), was spun off from Illumina in June 2024 […]
Apetito readies plans for new frozen meals facility in UK
The UK unit of the Germany-based business is building the new site next to existing premises in Trowbridge, Wiltshire.
Jim Cramer Likes GRAIL, Inc. (GRAL) Despite Losses – Great Science, Risky Bet!
We recently published a list of Jim Cramer Put These 16 Stocks Under a Microscope. In this article, we are going to take a look at where GRAIL, Inc. (NASDAQ:GRAL) stands against other stocks that Jim Cramer put under a microscope. On Thursday, Jim Cramer, the host of Mad Money, shared his thoughts on the […]
Jim Cramer Says Mosaic (MOS) Is a Simple Bet on Fertilizer – Commodity Play!
We recently published a list of Jim Cramer Looked At These 23 Stocks Recently. In this article, we are going to take a look at where Mosaic Company (NYSE:MOS) stands against other stocks that Jim Cramer looked at recently. Jim Cramer, the host of Mad Money, offered an optimistic perspective on the market on Thursday […]
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
/PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that it has...
GRAIL to Present at TD Cowen 45th Annual Health Care Conference
/PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company...
GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results
/PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and...
Top 5 Biotech Stocks That Got Most Retail Buzz Last Week
From merger updates to earnings surprises, these healthcare stocks saw the biggest spike in Stocktwits chatter.